Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00053742
Recruitment Status : Completed
First Posted : February 5, 2003
Last Update Posted : March 4, 2008
Information provided by:
National Institutes of Health Clinical Center (CC)